Are fibroblasts involved in joint destruction?

Annals of the Rheumatic Diseases

Volumn 64, Issue SUPPL. 4, 2005, Pages

  Pap, T ^a   Meinecke, I ^a   Muller Ladner U ^b   Gay, S ^c  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^b JUSTUS LIEBIG UNIVERSITY   (Germany)

^c UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CATHEPSIN; COLLAGENASE 3; INTERSTITIAL COLLAGENASE; MATRIX METALLOPROTEINASE; OSTEOCLAST DIFFERENTIATION FACTOR; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 3; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1;

CARTILAGE DEGENERATION; COMBINED IMMUNODEFICIENCY; CONFERENCE PAPER; EXTRACELLULAR MATRIX; FIBROBLAST; HUMAN; JOINT DESTRUCTION; NONHUMAN; ONCOGENE MYB; ONCOGENE MYC; ONCOGENE RAS; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SYNOVIUM;

ANIMALS; ARTHRITIS, RHEUMATOID; FIBROBLASTS; HUMANS; MATRIX METALLOPROTEINASES; MICE; MICE, SCID; SYNOVIAL MEMBRANE;

EID: 27444446925     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.2005.042424     Document Type: Conference Paper

References (30)

1. Fassbender HG. Histomorphological basis of articular cartilage destruction in rheumatoid arthritis. Coll Relat Res 1983;3:141-55.
2. Shigeyama Y, Pap T, Kunzler P, Simmen BR, Gay RE, Gay S. Expression of osteoclast differentiation factor in rheumatoid arthritis. Arthritis Rheum 2000;43:2523-30.
3. Pap T, Gay RE, Gay S. Mechanisms of joint destruction. In: Wollheim F, Firestein GS, Panayi G, eds. Rheumatoid arthritis: The new frontiers in pathogenesis and treatment. Oxford: Oxford University Press, 2005.
4. Pap T, Müller-Ladner U, Hummel KM, Gay RE, Gay S. Studies in the SCID mouse model. In: Evans C, Robbins P, eds. Gene Therapy in Inflammatory Diseases. Basel, Switzerland: Birkenhäuser, 1998.
5. Adams CD, Zhou T, Mountz JD. Transplantation of human synovium into a SCID mouse as a model for disease activity. Arthritis Rheum 1990;33(suppl):S120.
6. Rendt KE, Barry TS, Jones DM, Richter CB, McCachren SS, Haynes BF. Engraftment of human synovium into severe combined immune deficient mice. Migration of human peripheral blood T cells to engrafted human synovium ana to mouse lymph nodes. J Immunol 1993;151:7324-36.
7. Geiler T, Kriegsmann J, Keyszer GM, Gay RE, Gay S. A new model for rheumatoid arthritis generated by engraftment of rheumatoid synovial tissue and normal human cartilage into SCID mice. Arthritis Rheum 1994;37:1664-71.
8. Müller-Ladner U, Kriegsmann J, Franklin BN, Matsumoto S, Geiler T, Gay RE, et al. Synovial fibroblasts of patients with rheumatoid arthritis attach to and invade normal human cartilage when engrafted into SCID mice. Am J Pathol 1996;149:1607-15.
9. Pap T, Claus A, Ohtsu S, Hummel KM, Schwartz P, Drynda S, et al. Osteoclast-independent bone resorption by fibroblast-like cells. Arthritis Res Ther 2003;5:R163-73.
10. Pap T, Schett G, Gay S. Matrix metalloproteinases. In: Smolen J, Lipsky J, eds. Targeted therapies in rheumatology. London: Martin Dunitz 2002.
11. Müller-Ladner U, Gay RE, Gay S. Activation of synoviocytes. Curr Opin Rheumatol 2000;12:186-94.
12. Müller-Ladner U, Kriegsmann J, Gay RE, Gay S. Oncogenes in rheumatoid synovium. Rheum Dis Clin North Am 1995;21:675-90.
13. Pap T, Nawrath M, Heinrich J, Bosse M, Baier A, Hummel KM, et al. Cooperation of Ras- and c-Myc-dependent pathways in regulating the growth and invasiveness of synovial fibroblasts in rheumatoid arthritis. Arthritis Rheum 2004;50:2794-802.
14. Konttinen YT, Ainola M, Valleala H, Ma J, Ida H, Mandelin J, et al. Analysis of 16 different matrix metalloproteinases (MMP-1 to MMP-20) in the synovial membrane: different profiles in trauma and rheumatoid arthritis. Ann Rheum Dis 1999;58:691-7.
15. Sorsa T, Konttinen YT, Lindy O, Ritchlin C, Saari H, Suomalainen K, et al. Collagenase in synovitis of rheumatoid arthritis. Semin Arthritis Rheum 1992;22:44-53.
16. Maeda S, Sawai T, Uzuki M, Takahashi Y, Omoto H, Seki M, et al. Determination of interstitial collagenase (MMP-1) in patients with rheumatoid arthritis. Ann Rheum Dis 1995;54:970-5.
17. Tolboom TC, Pieterman E, van der Laan WH, Toes RE, Huidekoper AL, Nelissen RG, et al. Invasive properties of fibroblast-like synoviocytes: correlation with growth characteristics and expression of MMP-1, MMP-3, and MMP-10. Ann Rheum Dis 2002;61:975-80.
18. Rutkauskaite E, Zacharias W, Schedel J, Muller-Ladner U, Mawrin C, Seemayer CA, et al. Ribozymes that inhibit the production of matrix metalloproteinase 1 reduce the invasiveness of rheumatoid arthritis synovial fibroblasts. Arthritis Rheum 2004;50:1448-56.
19. Firestein GS, Paine MM. Stromelysin and tissue inhibitor of metalloproteinases gene expression in rheumatoid arthritis synovium. Am J Pathol 1992;140:1309-14.
20. Clark IM, Powell LK, Ramsey S, Hazelman BL, Cawston TE. The measurement of collagenase, TIMP and collagenase-TIMP complex in synovial fluids from patients with osteoarthritis and rheumatoid arthritis. Arthritis Rheum 1993;36:372-80.
21. DiBattista JA, Pelletier JP, Zafarullah M, Fujimoto N, Obata K, Martel PJ. Coordinate regulation of matrix metalloproteases and tissue inhibitor of metalloproteinase expression in human synovial fibroblasts. J Rheumatol Suppl 1995;43:123-8.
22. van der Loan WH, Quax PH, Seemayer CA, Huisman LG, Pieterman E, Grimbergen JM, et al. Cartilage degradation and invasion by rheumatoid synovial fibroblasts is inhibited by gene transfer of TIMP-1 and TIMP-3. Gene Ther 2003;10:234-42.
23. Smith MR, Kung H, Durum SK, Colburn NH, Sun Y. TIMP-3 induces cell death by stabilizing TNF-alpha receptors on the surface of human colon carcinoma cells. Cytokine 1997;9:770-80.
24. Hargreaves PG, Wang F, Antcliff J, Murphy G, Lawry J, Russell RG, et al. Human myeloma cells shed the interleukin-6 receptor: inhibition by tissue inhibitor of metalloproteinase-3 and a hydroxamate-based metalloproteinase inhibitor. Br J Haematol 1998;101:694-702.
25. Amour A, Slocombe PM, Webster A, Butler M, Knight CG, Smith BJ, et al. TNF-alpha converting enzyme (TACE) is inhibited by TIMP-3. FEBS Lett 1998;435:39-44.
26. Ahonen M, Baker AH, Kahari VM. Adenovirus-mediated gene delivery of tissue inhibitor of metalloproteinases-3 inhibits invasion ana induces apoptosis in melanoma cells. Cancer Res 1998;58:2310-15.
27. Baker AH, Zaltsman AB, George SJ, Newby AC. Divergent effects of tissue inhibitor of metalloproteinase-1, -2, or -3 overexpression on rat vascular smooth muscle cell invasion, proliferation, and death in vitro. TIMP-3 promotes apoptosis. J Clin Invest 1998;101:1478-87.
28. Baker AH, George SJ, Zaltsman AB, Murphy G, Newby AC. Inhibition of invasion and induction of apoptotic cell death of cancer cell lines by overexpression of TIMP-3. Br J Cancer 1999;79:1347-55.
29. Majid MA, Smith VA, Easty DL, Baker AH, Newby AC. Adenovirus mediated gene delivery of tissue inhibitor of metalloproteinases-3 induces death in retinal pigment epithelial cells. Br J Ophthalmol 2002;86:97-101.
30. Drynda A, Quax PH, Neumann M, van der Laan WH, Pap G, Drynda S, et al. Gene transfer of tissue inhibitor of metalloproteinases-3 reverses the inhibitory effects of TNF-{alpha} on fas-induced apoptosis in rheumatoid arthritis synovial fibroblasts. J Immunol 2005;174:6524-31.